Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
BioAge Labs’ $238 Million Upsized Initial Public Offering
ChrysCapital’s Closing of $700 Million Continuation Fund
Cooley advised ChrysCapital on the deal. ChrysCapital, a top India-focused private equity firm, announced the close of its oversubscribed $700 million continuation fund with two of the...
Capidea’s Acquistion of Interest in Right People Group
Accura advised Capidea in connection with the transaction. The Danish private equity fund Capidea has acquired a controlling interest in Right People Group. Right People Group...
ImmuneOnco Biopharmaceuticals’ HK$319 Million IPO
Cooley and JunHe advised ImmuneOnco Biopharmaceuticals on the offering, and Kirkland & Ellis and Jingtian & Gongcheng advised the joint sponsors and underwriters. ImmuneOnco Biopharmaceuticals announced...
Vietnam Sunergy Cell Company’s Business Combination with Blue World Acquisition
Cooley acted as U.S. legal advisor to Vietnam Sunergy Cell Company, and Robinson & Cole acted as U.S. legal advisor to Blue World. Vietnam Sunergy Cell...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
PCCW Limited’s Strategic Partnership With Canal+
Slaughter and May advised PCCW Limited. PCCW Limited completed its strategic partnership with the CANAL+ group in relation to Viu International Limited, an OTT video streaming service with...
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
Osmos’ Merger with Rankmi
Barros & Errázuriz Abogados and Mijares, Angoitia, Cortés y Fuentes, S.C. represented Osmos. Villarino e Ilharreborde Abogados, Ritch, Mueller, Heather y Nicolau and Cooley LLP represented...
Structure Therapeutics’ $185.3 Million IPO
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
M33 Growth’s Closing of $340 Million Third Fund
Cooley advised M33 Growth on the deal. M33 Growth, a venture and growth-stage investment firm, announced the closing of its third fund at $340 million. Investors in...
Swire Properties Limited’s Acquisition of Interests in Sino-Ocean Taikoo Li Chengdu
Slaughter and May, Hong Kong, advised Swire Properties Limited on the deal while Paul Hastings LLP represented Sino-Ocean Group. Swire Properties Limited (“Swire Properties”) acquired the...